The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
A viral inhibitor of peptide transporters for antigen presentation
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., & Goldberg, A. L. (1994) · Cell · doi:10.1016/s0092-8674(94)90462-6 · Cited by 2,524
Association of class I major histocompatibility heavy and light chains induced by viral peptides
Townsend, A., Öhlén, C., Bastin, J., Ljunggren, H.-G., Foster, L., & Kärre, K. (1989) · Nature · doi:10.1038/340443a0 · Cited by 985
Jackson, M. R., Nilsson, T., & Peterson, P. A. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07513.x · Cited by 908
Self-citationUse of a Monoclonal Antibody (W6/32) in Structural Studies of HLA-A,B,C Antigens
Parham, P., Barnstable, C. J., & Bodmer, W. F. (1979) · The Journal of Immunology · doi:10.4049/jimmunol.123.1.342 · Cited by 673
A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes
York, I. A., Roop, C., Andrews, D. W., Riddell, S. R., Graham, F. L., & Johnson, D. C. (1994) · Cell · doi:10.1016/0092-8674(94)90215-1 · Cited by 559
Selective and ATP-Dependent Translocation of Peptides by the MHC-Encoded Transporter
Neefjes, J. J., Momburg, F., & Hämmerling, G. J. (1993) · Science · doi:10.1126/science.8342042 · Cited by 549
Transport Protein Genes in the Murine MHC: Possible Implications for Antigen Processing
Monaco, J. J., Cho, S., & Attaya, M. (1990) · Science · doi:10.1126/science.2270487 · Cited by 430
Antibodies to the Golgi complex and the rough endoplasmic reticulum.
Louvard, D., Reggio, H., & Warren, G. (1982) · The Journal of cell biology · doi:10.1083/jcb.92.1.92 · Cited by 416
TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective
Shepherd, J. C., Schumacher, T. N. M., Ashton-Rickardt, P. G., Imaeda, S., Ploegh, H. L., Janeway, C. A., & Tonegawa, S. (1993) · Cell · doi:10.1016/0092-8674(93)80058-m · Cited by 368
Cited by
Wiertz, E. J. H. J., Jones, T. R., Sun, L., Bogyo, M., Geuze, H. J., & Ploegh, H. L. (1996) · Cell · doi:10.1016/s0092-8674(00)81054-5 · Cited by 1,072
Schwartz, O., Maréchal, V., Gall, S. L., Lemonnier, F., & Heard, J.-M. (1996) · Nature Medicine · doi:10.1038/nm0396-338 · Cited by 1,060
Viral Subversion of the Immune System
Tortorella, D., Gewurz, B. E., Furman, M. H., Schust, D. J., & Ploegh, H. L. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.861 · Cited by 835
Oncolytic virus therapy: A new era of cancer treatment at dawn
Fukuhara, H., Ino, Y., & Todo, T. (2016) · Cancer Science · doi:10.1111/cas.13027 · Cited by 774
Cross‐presentation, dendritic cell subsets, and the generation of immunity to cellular antigens
Heath, W. R., Belz, G. T., Behrens, G. M. N., Smith, C. M., Forehan, S. P., Parish, I. A., Davey, G. M., Wilson, N. S., Carbone, F. R., & Villadangos, J. A. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00142.x · Cited by 735
ANTIGEN PROCESSING AND PRESENTATION BY THE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX
York, I. A., & Rock, K. L. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.369 · Cited by 610
Riddell, S. R., Elliott, M., Lewinsohn, D. A., Gilbert, M. J., Wilson, L., Manley, S. A., Lupton, S. D., Overell, R. W., Reynolds, T. C., Corey, L., et al. (1996) · Nature Medicine · doi:10.1038/nm0296-216 · Cited by 565
The neurotropic herpes viruses: herpes simplex and varicella-zoster
Steiner, I., Kennedy, P. G., & Pachner, A. R. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70267-3 · Cited by 564
The MHC class I antigen presentation pathway: strategies for viral immune evasion
Hewitt, E. W. (2003) · Immunology · doi:10.1046/j.1365-2567.2003.01738.x · Cited by 487
Saveanu, L., Carroll, O., Lindo, V., Del Val, M., Lopez, D., Lepelletier, Y., Greer, F., Schomburg, L., Fruci, D., Niedermann, G., et al. (2005) · Nature Immunology · doi:10.1038/ni1208 · Cited by 481
Cross-presentation in viral immunity and self-tolerance
Heath, W. R., & Carbone, F. R. (2001) · Nature Reviews Immunology · doi:10.1038/35100512 · Cited by 480
The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP
Ahn, K., Gruhler, A., Galocha, B., Jones, T. R., Wiertz, E. J. H. J., Ploegh, H. L., Peterson, P. A., Yang, Y., & Früh, K. (1997) · Immunity · doi:10.1016/s1074-7613(00)80349-0 · Cited by 477
Self-citationCoscoy, L., & Ganem, D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.140129797 · Cited by 476
Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing
Todo, T., Martuza, R. L., Rabkin, S. D., & Johnson, P. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101136398 · Cited by 465
Ishido, S., Wang, C., Lee, B.-S., Cohen, G. B., & Jung, J. U. (2000) · Journal of Virology · doi:10.1128/.74.11.5300-5309.2000 · Cited by 459
MHC class I antigen presentation: learning from viral evasion strategies
Hansen, T. H., & Bouvier, M. (2009) · Nature Reviews Immunology · doi:10.1038/nri2575 · Cited by 426
CD8 T Cell Responses to Infectious Pathogens
Wong, P., & Pamer, E. G. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141114 · Cited by 425
Oncolytic viruses as engineering platforms for combination immunotherapy
Twumasi-Boateng, K., Pettigrew, J. L., Kwok, Y. Y. E., Bell, J. C., & Nelson, B. H. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0009-4 · Cited by 417
Jones, T. R., Wiertz, E. J., Sun, L., Fish, K. N., Nelson, J. A., & Ploegh, H. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11327 · Cited by 414
Liu, T., Khanna, K. M., Chen, X., Fink, D. J., & Hendricks, R. L. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.9.1459 · Cited by 385
Human cytomegalovirus inhibits antigen presentation by a sequential multistep process.
Ahn, K., Angulo, A., Ghazal, P., Peterson, P. A., Yang, Y., & Früh, K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10990 · Cited by 378
Self-citationInhibition of dendritic cell maturation by herpes simplex virus
Salio, M., Cella, M., Suter, M., & Lanzavecchia, A. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199910)29:10<3245::aid-immu3245>3.0.co;2-x · Cited by 365
Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47.
Ahn, K., Meyer, T. H., Uebel, S., Sempé, P., Djaballah, H., Yang, Y., Peterson, P. A., Früh, K., & Tampé, R. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00689.x · Cited by 358
Self-citationThe Genome Sequence of Herpes Simplex Virus Type 2
Dolan, A., Jamieson, F. E., Cunningham, C., Barnett, B. C., & McGeoch, D. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2010-2021.1998 · Cited by 355
Steven, N. M., Annels, N. E., Kumar, A., Leese, A. M., Kurilla, M. G., & Rickinson, A. B. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1605 · Cited by 350
Implication of γδ T cells in the human immune response to cytomegalovirus
Déchanet, J., Merville, P., Lim, A., Retière, C., Pitard, V., Lafarge, X., Michelson, S., Méric, C., Hallet, M.-M., Kourilsky, P., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5409 · Cited by 338
Direct Link Between mhc Polymorphism, T Cell Avidity, and Diversity in Immune Defense
Messaoudi, I., Patiño, J. A. G., Dyall, R., LeMaoult, J., & Nikolich-Žugich, J. (2002) · Science · doi:10.1126/science.1076064 · Cited by 323
A Viral ER-Resident Glycoprotein Inactivates the MHC-Encoded Peptide Transporter
Hengel, H., Koopmann, J.-O., Flohr, T., Muranyi, W., Goulmy, E., Hämmerling, G. J., Koszinowski, U. H., & Momburg, F. (1997) · Immunity · doi:10.1016/s1074-7613(00)80350-7 · Cited by 315
Lamp-2a Facilitates MHC Class II Presentation of Cytoplasmic Antigens
Zhou, D., Li, P., Lin, Y., Lott, J. M., Hislop, A. D., Canaday, D. H., Brutkiewicz, R. R., & Blum, J. S. (2005) · Immunity · doi:10.1016/j.immuni.2005.03.009 · Cited by 309
Hughes, E. A., Hammond, C., & Cresswell, P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1896 · Cited by 299
Soluble Tapasin Restores MHC Class I Expression and Function in the Tapasin-Negative Cell Line .220
Lehner, P. J., Surman, M. J., & Cresswell, P. (1998) · Immunity · doi:10.1016/s1074-7613(00)80474-4 · Cited by 294
Stem cell medicine encounters the immune system
Bradley, J. A., Bolton, E. M., & Pedersen, R. A. (2002) · Nature Reviews Immunology · doi:10.1038/nri934 · Cited by 290
The molecular basis of herpes simplex virus latency
Nicoll, M. P., Proença, J. T., & Efstathiou, S. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00320.x · Cited by 286
Lehner, P. J., Karttunen, J. T., Wilkinson, G. W. G., & Cresswell, P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6904 · Cited by 283
Coscoy, L., Sanchez, D. J., & Ganem, D. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200111010 · Cited by 282
Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP.
Tomazin, R., Hill, A. B., Jugovic, P., York, I., van Endert, P., Ploegh, H. L., Andrews, D. W., & Johnson, D. C. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00690.x · Cited by 273
Self-citationZiegler, H., Thäle, R., Lucin, P., Muranyi, W., Flohr, T., Hengel, H., Farrell, H., Rawlinson, W., & Koszinowski, U. H. (1997) · Immunity · doi:10.1016/s1074-7613(00)80242-3 · Cited by 266
Blake, N., Lee, S., Redchenko, I., Thomas, W., Steven, N., Leese, A., Steigerwald-Mullen, P., Kurilla, M. G., Frappier, L., & Rickinson, A. (1997) · Immunity · doi:10.1016/s1074-7613(00)80397-0 · Cited by 261
Viral immune evasion: a masterpiece of evolution
Vossen, M. T., Westerhout, E. M., Söderberg-Nauclér, C., & Wiertz, E. J. (2002) · Immunogenetics · doi:10.1007/s00251-002-0493-1 · Cited by 261
Viral interference with antigen presentation
Yewdell, J. W., & Hill, A. B. (2002) · Nature Immunology · doi:10.1038/ni1102-1019 · Cited by 259
Peh, C. A., Burrows, S. R., Barnden, M., Khanna, R., Cresswell, P., Moss, D. J., & McCluskey, J. (1998) · Immunity · doi:10.1016/s1074-7613(00)80558-0 · Cited by 252
Gene Delivery Using Herpes Simplex Virus Vectors
Burton, E. A., Fink, D. J., & Glorioso, J. C. (2002) · DNA and Cell Biology · doi:10.1089/104454902762053864 · Cited by 92
Huang, T., Lehmann, M. J., Said, A., Ma, G., & Osterrieder, N. (2014) · Journal of Virology · doi:10.1128/jvi.02079-14 · Cited by 24
Inhibition of antigen presentation during AAV gene therapy using virus peptides
Shao, W., Chen, X., Samulski, R. J., Hirsch, M. L., & Li, C. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddx427 · Cited by 17
Metadata
- Authors
- Früh, K., Ahn, K., Djaballah, H., Sempé, P., van Endert, P. M., Tampé, R., Peterson, P. A., & Yang, Y.
- Venue
- Nature
- Published
- 1995-06
- Volume
- 375
- Issue
- 6530
- Pages
- 415-418
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2018106813
- Cited by
- 602
- References
- 20
- FWCI
- 17.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.